BG

Bellevue Group Portfolio holdings

AUM $4.81B
1-Year Est. Return 29.28%
This Quarter Est. Return
1 Year Est. Return
+29.28%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$6.97B
AUM Growth
-$106M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
187
New
Increased
Reduced
Closed

Top Buys

1
+$25.6M
2
+$24.6M
3
+$12.1M
4
TNDM icon
Tandem Diabetes Care
TNDM
+$12M
5
CRL icon
Charles River Laboratories
CRL
+$6.28M

Top Sells

1
+$91.2M
2
+$42.4M
3
+$26.3M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$20.3M
5
AXSM icon
Axsome Therapeutics
AXSM
+$14.3M

Sector Composition

1 Healthcare 99.34%
2 Industrials 0.59%
3 Energy 0.02%
4 Communication Services 0.01%
5 Technology 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
126
$1.65M 0.02%
318,300
127
$1.61M 0.02%
11,910
-1,090
128
$1.46M 0.02%
388,368
-119,562
129
$1.42M 0.02%
+41,634
130
$1.28M 0.02%
+36,600
131
$1.28M 0.02%
18,300
+4,900
132
$1.24M 0.02%
+6,600
133
$1.1M 0.02%
385,014
134
$1.05M 0.02%
136,133
135
$1.05M 0.02%
+8,627
136
$999K 0.01%
2,938
+401
137
$951K 0.01%
+31,000
138
$946K 0.01%
46,100
-2,900
139
$940K 0.01%
+7,000
140
$799K 0.01%
4,540
-407
141
$781K 0.01%
43,500
-33,100
142
$699K 0.01%
66,300
-4,000
143
$664K 0.01%
62,000
144
$660K 0.01%
25,400
-1,100
145
$643K 0.01%
+1,800
146
$583K 0.01%
+34,881
147
$577K 0.01%
6,000
148
$509K 0.01%
+25,400
149
$502K 0.01%
7,062
-17,845
150
$486K 0.01%
+3,900
4 5
6
7 8